Baird Downgrades Crown Holdings to Neutral, Announces $80 Price Target
Baird analyst Ghansham Panjabi downgrades Crown Holdings (NYSE:CCK) from Outperform to Neutral and announces $80 price target.
Stifel Downgrades Apollo Endosurgery to Hold, Announces $10 Price Target
Stifel analyst Mathew Blackman downgrades Apollo Endosurgery (NASDAQ:APEN) from Buy to Hold and announces $10 price target.
Apple Crossed The Whopping $3 Trillion Mark Exactly A Year Ago Today — Now, It’s Not Even In The $2 Trillion Club
Apple Inc’s (NASDAQ: AAPL) valuation fell below the $2 trillion mark on Tuesday for the first time since March 20
Why This Bank Analyst Is No Longer Bullish On Ally, Capital One
Banks are entering 2023 in a state of alert as national and global economies slide into a period of ever-increasing uncertainty.
Why This Fox Analyst Downgrades Stock, Even As Murdoch Contemplates Merger With News Corp
Shares of Fox Corp (NASDAQ: FOXA) have been in focus following reports of Rupert Murdoch weighing a merger of the company with
Northland Capital Markets Downgrades Telos to Market Perform, Announces $5 Price Target
Northland Capital Markets analyst Nehal Chokshi downgrades Telos (NASDAQ:TLS) from Outperform to Market Perform and announces $5 price target.
Noble Capital Markets Downgrades Baudax Bio to Market Perform
Noble Capital Markets analyst Gregory Aurand downgrades Baudax Bio (NASDAQ:BXRX) from Outperform to Market Perform.
B of A Securities Downgrades Baxter Intl to Neutral, Announces $55 Price Target
B of A Securities analyst Travis Steed downgrades Baxter Intl (NYSE:BAX) from Buy to Neutral and announces $55 price target.
Wells Fargo Downgrades Cigna to Equal-Weight, Announces $355 Price Target
Wells Fargo downgrades Cigna (NYSE:CI) from Overweight to Equal-Weight and announces $355 price target.
RBC Capital Downgrades Shaw Comms to Sector Perform, Announces C$40.5 Price Target
RBC Capital analyst Drew McReynolds downgrades Shaw Comms (TSX:SJR) from Outperform to Sector Perform and announces C$40.5 price target.